Combination of Oncolytic Herpes Simplex Viruses Armed with Angiostatin and IL-12 Enhances Antitumor Efficacy in Human Glioblastoma Models
Oncolytic herpes simplex virus (oHSV) can potentially spread throughout the tumor, reach isolated infiltrating cells, kill them, and deliver anticancer agents. However, the host responds to oHSV by inducing intratumoral infiltration of macrophages that can engulf the virus, limiting the potential of...
Main Authors: | Wei Zhang, Giulia Fulci, Hiroaki Wakimoto, Tooba A. Cheema, Jason S. Buhrman, Deva S. Jeyaretna, Anat O. Stemmer Rachamimov, Samuel D. Rabkin, Robert L. Martuza |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2013-06-01
|
Series: | Neoplasia: An International Journal for Oncology Research |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1476558613801327 |
Similar Items
-
Oncolytic herpes simplex virus expressing IL-2 controls glioblastoma growth and improves survival
by: Howard L Kaufman, et al.
Published: (2024-04-01) -
Histone deacetylase inhibitors enhance oncolytic herpes simplex virus therapy for malignant meningioma
by: Yoichiro Kawamura, et al.
Published: (2022-11-01) -
Oncolytic herpes simplex viruses for the treatment of glioma and targeting glioblastoma stem-like cells
by: Kimia Kardani, et al.
Published: (2023-05-01) -
Oncolytic Herpes Simplex Virus-Based Therapies for Cancer
by: Norah Aldrak, et al.
Published: (2021-06-01) -
Oncolytic Herpes Simplex Virus and PI3K Inhibitor BKM120 Synergize to Promote Killing of Prostate Cancer Stem-like Cells
by: Lei Wang, et al.
Published: (2019-06-01)